s6y

Veradermics, Inc

Ticker
MANE
CIK
1827635
Industry
Pharmaceutical Preparations

Financials 4

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K Annual Report for period ending Dec 31, 2025

News 11

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 11 news filings

Ownership 37

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 3 Initial statement of beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 3 Initial statement of beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 37 ownership filings

Prospectus 15

  1. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  2. S-1 General form of registration statement for all companies including face-amount certificate companies
  3. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  4. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  5. S-1MEF A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1
  6. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  7. S-1 General form of registration statement for all companies including face-amount certificate companies
  8. DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  9. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  10. 424B4 Prospectus filed pursuant to Rule 424(b)(4)

All 15 prospectus filings

Other 37

  1. SCHEDULE 13D/A
  2. 144 Filing for proposed sale of securities under Rule 144
  3. SCHEDULE 13G
  4. SCHEDULE 13D/A
  5. 144 Filing for proposed sale of securities under Rule 144
  6. 144 Filing for proposed sale of securities under Rule 144
  7. 144 Filing for proposed sale of securities under Rule 144
  8. 144 Filing for proposed sale of securities under Rule 144
  9. EFFECT Notice of Effectiveness
  10. 144/A Filing for proposed sale of securities under Rule 144

All 37 other filings